BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

March 31, 2013

Conditions

Healthy

Interventions

DRUG

gemigliptin and metformin HCl extended release

Coadministration of gemigliptin 50mg and metformin HCl extended release 1000mg, for 1 day

DRUG

gemigliptin/metformin HCl extended release

Administration of combination of gemigliptin 50mg/metformin HCl extended release 500mg, for 1day.

Trial Locations (1)

Seoul National University Hospital, Seoul